Guest Contributors

Will Lee, VP of Science at Helix
Brendan Lee, President of ASHG
CEO, Microsonic Systems
David Lennon, CEO of Satellite Bio
Philosopher, University of Exeter
Emily Leproust, CEO and Co-Founder, Twist Bioscience
Olivier Lesueur, Partner at Bionest
Tony Letai, Associate Professor, Harvard Medical School and Dana-Farber Cancer Institute
Managing Director, Burrill & Company
Daniel Levner Co-Founder and Chairman of the Scientific Advisory Board, Sight Dx
Ivan Liachko, CEO & CSO of Phase Genomics
Founder, Rare Genomics Institute
Director of the Bioinformatics Core at UC Davis Genome Center
Shirley Liu, Professor of Biostatisitcs at Harvard, Co-Director of the Center for Fuctional Cancer Epigenetics at the Dana Farber Cancer Institute
Terry Lo, CEO at Vizgen
Matt Loose, Professor of Developmental and Computational Biology, Faculty of Medicine & Health Sciences, University of Nottingham
Professor, University of Illinois
CEO, Assay Depot
Clinical Services Lab Director at HudsonAlpha Institute for Biotechnology
Sandy Macrae, CEO of Sangamo
President and CEO, BayBio
Jerome Madison, General Manager of Oncology for Invitae
Science Comedian
Deputy Office Director of Personalized Medicine, OIR, FDA